 | • レポートコード：MRC2012A5549 • 出版社/出版日：GlobalInfoResearch / 2020年12月24日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医薬品、医療 |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、肝線維症治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。肝線維症治療薬の種類別市場規模（ヌクレオシド、インターフェロン、その他）、用途別市場規模（肝炎、肝線維症、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Gilead、Bristol-Myers Squibb Company、Biogen Idec、Tri-Prime、Merck KGaA、Merck & Co.、Roche、 ・地域別グローバル市場分析 2015年-2020年 ・肝線維症治療薬の北米市場（アメリカ、カナダ、メキシコ） ・肝線維症治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・肝線維症治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・肝線維症治療薬の南米市場（ブラジル、アルゼンチン） ・肝線維症治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：ヌクレオシド、インターフェロン、その他 ・用途別分析：肝炎、肝線維症、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The Liver Fibrosis Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
The global Liver Fibrosis Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of -1.6%% in the forecast period of 2020 to 2025 and will expected to reach USD 13290 million by 2025, from USD 14190 million in 2019.
Market segmentation
Liver Fibrosis Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Liver Fibrosis Drug market has been segmented into
Nucleoside
Interferon
Other
By Application, Liver Fibrosis Drug has been segmented into:
Hepatitis
Liver Fibrosis
Other
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Liver Fibrosis Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Liver Fibrosis Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Liver Fibrosis Drug market.
The report offers in-depth assessment of the growth and other aspects of the Liver Fibrosis Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Liver Fibrosis Drug Market Share Analysis
Liver Fibrosis Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Liver Fibrosis Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Liver Fibrosis Drug sales, revenue and market share for each player covered in this report.
The major players covered in Liver Fibrosis Drug are:
Gilead
Bristol-Myers Squibb Company
Biogen Idec
Tri-Prime
Merck KGaA
Merck & Co.
Roche
Among other players domestic and global, Liver Fibrosis Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Liver Fibrosis Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Liver Fibrosis Drug, with price, sales, revenue and global market share of Liver Fibrosis Drug in 2018 and 2019.
Chapter 3, the Liver Fibrosis Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Liver Fibrosis Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Liver Fibrosis Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Liver Fibrosis Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
1 Market Overview
1.1 Liver Fibrosis Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Liver Fibrosis Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Nucleoside
1.2.3 Interferon
1.2.4 Other
1.3 Market Analysis by Application
1.3.1 Overview: Global Liver Fibrosis Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hepatitis
1.3.3 Liver Fibrosis
1.3.4 Other
1.4 Overview of Global Liver Fibrosis Drug Market
1.4.1 Global Liver Fibrosis Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Gilead
2.1.1 Gilead Details
2.1.2 Gilead Major Business
2.1.3 Gilead SWOT Analysis
2.1.4 Gilead Product and Services
2.1.5 Gilead Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Bristol-Myers Squibb Company
2.2.1 Bristol-Myers Squibb Company Details
2.2.2 Bristol-Myers Squibb Company Major Business
2.2.3 Bristol-Myers Squibb Company SWOT Analysis
2.2.4 Bristol-Myers Squibb Company Product and Services
2.2.5 Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Biogen Idec
2.3.1 Biogen Idec Details
2.3.2 Biogen Idec Major Business
2.3.3 Biogen Idec SWOT Analysis
2.3.4 Biogen Idec Product and Services
2.3.5 Biogen Idec Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Tri-Prime
2.4.1 Tri-Prime Details
2.4.2 Tri-Prime Major Business
2.4.3 Tri-Prime SWOT Analysis
2.4.4 Tri-Prime Product and Services
2.4.5 Tri-Prime Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Merck KGaA
2.5.1 Merck KGaA Details
2.5.2 Merck KGaA Major Business
2.5.3 Merck KGaA SWOT Analysis
2.5.4 Merck KGaA Product and Services
2.5.5 Merck KGaA Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Merck & Co.
2.6.1 Merck & Co. Details
2.6.2 Merck & Co. Major Business
2.6.3 Merck & Co. Product and Services
2.6.4 Merck & Co. Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Roche
2.7.1 Roche Details
2.7.2 Roche Major Business
2.7.3 Roche Product and Services
2.7.4 Roche Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Liver Fibrosis Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Liver Fibrosis Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Liver Fibrosis Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Liver Fibrosis Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Liver Fibrosis Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Liver Fibrosis Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Liver Fibrosis Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
4.3 Europe Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
4.5 South America Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Liver Fibrosis Drug Sales, Revenue and Market Share by Country
5.1.1 North America Liver Fibrosis Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Liver Fibrosis Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
5.3 Canada Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Liver Fibrosis Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Liver Fibrosis Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Liver Fibrosis Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
6.3 UK Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
6.4 France Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
6.5 Russia Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
6.6 Italy Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Liver Fibrosis Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Liver Fibrosis Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Liver Fibrosis Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
7.3 Japan Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
7.4 Korea Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
7.5 India Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
7.7 Australia Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Liver Fibrosis Drug Sales, Revenue and Market Share by Country
8.1.1 South America Liver Fibrosis Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Liver Fibrosis Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Liver Fibrosis Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Liver Fibrosis Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Liver Fibrosis Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Liver Fibrosis Drug Sales and Market Share by Type (2015-2020)
10.2 Global Liver Fibrosis Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Liver Fibrosis Drug Price by Type (2015-2020)
11 Global Liver Fibrosis Drug Market Segment by Application
11.1 Global Liver Fibrosis Drug Sales Market Share by Application (2015-2020)
11.2 Global Liver Fibrosis Drug Revenue Market Share by Application (2015-2020)
11.3 Global Liver Fibrosis Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Liver Fibrosis Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Liver Fibrosis Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Liver Fibrosis Drug Market Forecast (2021-2025)
12.2.2 Europe Liver Fibrosis Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Liver Fibrosis Drug Market Forecast (2021-2025)
12.2.4 South America Liver Fibrosis Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Liver Fibrosis Drug Market Forecast (2021-2025)
12.3 Liver Fibrosis Drug Market Forecast by Type (2021-2025)
12.3.1 Global Liver Fibrosis Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Liver Fibrosis Drug Market Share Forecast by Type (2021-2025)
12.4 Liver Fibrosis Drug Market Forecast by Application (2021-2025)
12.4.1 Global Liver Fibrosis Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Liver Fibrosis Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Liver Fibrosis Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Liver Fibrosis Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Liver Fibrosis Drug Market Size and Growth Estimation in Various Scenarios in 2020
Table 4. Global Liver Fibrosis Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 5. Market Opportunities in Next Few Years
Table 6. Market Risks Analysis
Table 7. Market Drivers
Table 8. Gilead Basic Information, Manufacturing Base and Competitors
Table 9. Gilead Liver Fibrosis Drug Major Business
Table 10. Gilead Liver Fibrosis Drug Total Revenue (USD Million) (2018-2019)
Table 11. Gilead SWOT Analysis
Table 12. Gilead Liver Fibrosis Drug Product and Services
Table 13. Gilead Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 14. Bristol-Myers Squibb Company Basic Information, Manufacturing Base and Competitors
Table 15. Bristol-Myers Squibb Company Liver Fibrosis Drug Major Business
Table 16. Bristol-Myers Squibb Company Liver Fibrosis Drug Total Revenue (USD Million) (2018-2019)
Table 17. Bristol-Myers Squibb Company SWOT Analysis
Table 18. Bristol-Myers Squibb Company Liver Fibrosis Drug Product and Services
Table 19. Bristol-Myers Squibb Company Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 20. Biogen Idec Basic Information, Manufacturing Base and Competitors
Table 21. Biogen Idec Liver Fibrosis Drug Major Business
Table 22. Biogen Idec Liver Fibrosis Drug Total Revenue (USD Million) (2018-2019)
Table 23. Biogen Idec SWOT Analysis
Table 24. Biogen Idec Liver Fibrosis Drug Product and Services
Table 25. Biogen Idec Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 26. Tri-Prime Basic Information, Manufacturing Base and Competitors
Table 27. Tri-Prime Liver Fibrosis Drug Major Business
Table 28. Tri-Prime Liver Fibrosis Drug Total Revenue (USD Million) (2018-2019)
Table 29. Tri-Prime SWOT Analysis
Table 30. Tri-Prime Liver Fibrosis Drug Product and Services
Table 31. Tri-Prime Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 32. Merck KGaA Basic Information, Manufacturing Base and Competitors
Table 33. Merck KGaA Liver Fibrosis Drug Major Business
Table 34. Merck KGaA Liver Fibrosis Drug Total Revenue (USD Million) (2018-2019)
Table 35. Merck KGaA SWOT Analysis
Table 36. Merck KGaA Liver Fibrosis Drug Product and Services
Table 37. Merck KGaA Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 38. Merck & Co. Basic Information, Manufacturing Base and Competitors
Table 39. Merck & Co. Liver Fibrosis Drug Major Business
Table 40. Merck & Co. Liver Fibrosis Drug Total Revenue (USD Million) (2018-2019)
Table 41. Merck & Co. SWOT Analysis
Table 42. Merck & Co. Liver Fibrosis Drug Product and Services
Table 43. Merck & Co. Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 44. Roche Basic Information, Manufacturing Base and Competitors
Table 45. Roche Liver Fibrosis Drug Major Business
Table 46. Roche Liver Fibrosis Drug Total Revenue (USD Million) (2018-2019)
Table 47. Roche SWOT Analysis
Table 48. Roche Liver Fibrosis Drug Product and Services
Table 49. Roche Liver Fibrosis Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 50. Global Liver Fibrosis Drug Sales by Manufacturer (2018-2019) (K Units)
Table 51. Global Liver Fibrosis Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 52. Global Liver Fibrosis Drug Sales by Regions (2015-2020) (K Units)
Table 53. Global Liver Fibrosis Drug Sales Market Share by Regions (2015-2020)
Table 54. Global Liver Fibrosis Drug Revenue by Regions (2015-2020) (USD Million)
Table 55. North America Liver Fibrosis Drug Sales by Countries (2015-2020) (K Units)
Table 56. North America Liver Fibrosis Drug Sales Market Share by Countries (2015-2020)
Table 57. North America Liver Fibrosis Drug Revenue by Countries (2015-2020) (USD Million)
Table 58. North America Liver Fibrosis Drug Revenue Market Share by Countries (2015-2020)
Table 59. Europe Liver Fibrosis Drug Sales by Countries (2015-2020) (K Units)
Table 60. Europe Liver Fibrosis Drug Sales Market Share by Countries (2015-2020)
Table 61. Europe Liver Fibrosis Drug Revenue by Countries (2015-2020) (USD Million)
Table 62. Asia-Pacific Liver Fibrosis Drug Sales by Regions (2015-2020) (K Units)
Table 63. Asia-Pacific Liver Fibrosis Drug Sales Market Share by Regions (2015-2020)
Table 64. Asia-Pacific Liver Fibrosis Drug Revenue by Regions (2015-2020) (USD Million)
Table 65. South America Liver Fibrosis Drug Sales by Countries (2015-2020) (K Units)
Table 66. South America Liver Fibrosis Drug Sales Market Share by Countries (2015-2020)
Table 67. South America Liver Fibrosis Drug Revenue by Countries (2015-2020) (USD Million)
Table 68. South America Liver Fibrosis Drug Revenue Market Share by Countries (2015-2020)
Table 69. Middle East & Africa Liver Fibrosis Drug Sales by Countries (2015-2020) (K Units)
Table 70. Middle East & Africa Liver Fibrosis Drug Sales Market Share by Countries (2015-2020)
Table 71. Middle East & Africa Liver Fibrosis Drug Revenue by Countries (2015-2020) (USD Million)
Table 72. Middle East & Africa Liver Fibrosis Drug Revenue Market Share by Countries (2015-2020)
Table 73. Global Liver Fibrosis Drug Sales by Type (2015-2020) (K Units)
Table 74. Global Liver Fibrosis Drug Sales Share by Type (2015-2020)
Table 75. Global Liver Fibrosis Drug Revenue by Type (2015-2020) (USD Million)
Table 76. Global Liver Fibrosis Drug Revenue Share by Type (2015-2020)
Table 77. Global Liver Fibrosis Drug Sales by Application (2015-2020) (K Units)
Table 78. Global Liver Fibrosis Drug Sales Share by Application (2015-2020)
Table 79. Global Liver Fibrosis Drug Sales Forecast by Regions (2021-2025) (K Units)
Table 80. Global Liver Fibrosis Drug Market Share Forecast by Regions (2021-2025)
Table 81. Global Liver Fibrosis Drug Sales Forecast by Type (2021-2025) (K Units)
Table 82. Global Liver Fibrosis Drug Market Share Forecast by Type (2021-2025)
Table 83. Global Liver Fibrosis Drug Sales Forecast by Application (2021-2025)
Table 84. Global Liver Fibrosis Drug Market Share Forecast by Application (2021-2025)
Table 85. Direct Channel Pros & Cons
Table 86. Indirect Channel Pros & Cons
Table 87. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Liver Fibrosis Drug Picture
Figure 2. Global Sales Market Share of Liver Fibrosis Drug by Type in 2019
Figure 3. Nucleoside Picture
Figure 4. Interferon Picture
Figure 5. Other Picture
Figure 6. Liver Fibrosis Drug Sales Market Share by Application in 2019
Figure 7. Hepatitis Picture
Figure 8. Liver Fibrosis Picture
Figure 9. Other Picture
Figure 10. Global Liver Fibrosis Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Liver Fibrosis Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Liver Fibrosis Drug Sales Market Share by Manufacturer in 2019
Figure 31. Global Liver Fibrosis Drug Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Liver Fibrosis Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Liver Fibrosis Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 36. Global Liver Fibrosis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Liver Fibrosis Drug Revenue Market Share by Regions (2015-2020)
Figure 38. Global Liver Fibrosis Drug Revenue Market Share by Regions in 2018
Figure 39. North America Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
Figure 40. Europe Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
Figure 42. South America Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Liver Fibrosis Drug Sales and Growth Rate (2015-2020)
Figure 44. North America Liver Fibrosis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Liver Fibrosis Drug Sales Market Share by Countries (2015-2020)
Figure 46. North America Liver Fibrosis Drug Sales Market Share by Countries in 2018
Figure 47. North America Liver Fibrosis Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Liver Fibrosis Drug Revenue Market Share by Countries in 2018
Figure 49. United States Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Canada Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Mexico Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Europe Liver Fibrosis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Liver Fibrosis Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Liver Fibrosis Drug Revenue Market Share by Countries in 2019
Figure 55. Germany Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 56. UK Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 57. France Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Russia Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Italy Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Asia-Pacific Liver Fibrosis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Liver Fibrosis Drug Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Liver Fibrosis Drug Revenue Market Share by Regions 2019
Figure 63. China Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Japan Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 65. Korea Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 66. India Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Southeast Asia Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 68. South America Liver Fibrosis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Liver Fibrosis Drug Sales Market Share by Countries in 2019
Figure 70. South America Liver Fibrosis Drug Revenue Market Share by Countries in 2019
Figure 71. Brazil Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Argentina Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 73. Middle East and Africa Liver Fibrosis Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Liver Fibrosis Drug Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Liver Fibrosis Drug Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Egypt Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 79. Turkey Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 80. South Africa Liver Fibrosis Drug Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Global Liver Fibrosis Drug Sales and Growth Rate (2021-2025) (K Units)
Figure 82. Global Liver Fibrosis Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Liver Fibrosis Drug Market Forecast (2021-2025) (K Units)
Figure 84. Europe Sales Liver Fibrosis Drug Market Forecast (2021-2025) (K Units)
Figure 85. Asia-Pacific Sales Liver Fibrosis Drug Market Forecast (2021-2025) (K Units)
Figure 86. South America Sales Liver Fibrosis Drug Market Forecast (2021-2025) (K Units)
Figure 87. Middle East & Africa Sales Liver Fibrosis Drug Market Forecast (2021-2025) (K Units)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
嚢胞性線維症（ムコビスコイドーシス）検査の世界市場（～2026年） Cystic Fibrosis, also known as mucoviscoidosis, is an inherited genetic disorder that affects the secretory glands, including mucus and sweat glands. It mainly affects the lungs and digestive system. An individual suffering from cystic fibrosis show characteristic symptoms, such as, secretion of thi…- 特発性肺線維症（IPF）の世界市場（～2026年） Idiopathic pulmonary fibrosis is a condition in which the tissues in the lungs become thick and stiff over time. As a result of thickening of lung tissues, brain and other organs are unable receive optimum oxygen. An increase in the incidence and prevalence of fibrotic diseases is the primary driver…
- 皮膚線維症治療の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Cutaneous Fibrosis Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimi…
- 非アルコール性脂肪性肝疾患治療の世界市場（～2026年） Fatty liver disease refers to the accumulation of fat (triglycerides,) in the liver. The liver cell contains fats, but the accumulation of excess fat can be a cause of concern and can lead to liver inflammation known as steatohepatitis. The fatty liver can be caused by alcohol as well as can be non-…
- 非アルコール性脂肪肝疾患治療薬の世界市場（～2026年） Nonalcoholic fatty liver disease (NAFLD) is a condition in which excessive fatty accumulation in the hepatocytes. There are two types of NAFLD, namely simple fatty liver and non-alcoholic steatohepatitis. In simple fatty liver, the fat in the liver is very less and there is no inflammation or liver …